Thursday September 21, 12:14 pm Eastern Time
Press Release
SOURCE: Bio-Imaging Technologies, Inc.
Bio-Imaging Technologies, Inc. Announces New Division -- Bio-Imaging, ETC.
NEWTOWN, Pa., Sept. 21 /PRNewswire/ -- Bio-Imaging Technologies, Inc. (OTC Bulletin Board: BITI - news), announced today the formation of a new division: Bio-Imaging ETC. Bio-Imaging ETC, will focus on Education, Training and Certification for medical imaging equipment, facilities, and staff. Bio-Imaging ETC will operate from the new regional Bio-Imaging office in Vancouver, Washington. Initially, the Division will take advantage of Bio-Imaging's unique expertise in bone densitometry. In coming months the scope of the division will be broadened to support clinical practitioners of other medical imaging technologies.
A program of Instrument Quality Control (IQC) will provide physicians with a method of ensuring that systems operate to specifications on a continual basis. This program is designed to protect the accuracy of diagnostic interpretation of bone density data and give the physicians current and in-depth feedback on the status of their instruments. The Division will continue Bio-Imaging's tradition for quality educational programs and other learning resources, and will target entry-level physician and allied health professionals in routine clinical practice.
Mr. Leonard Avecilla, MS, has joined Bio-Imaging ETC as Director of the division. Mr. Avecilla has both academic and commercial experience in imaging, diagnostic ultrasound and bone densitometry. Prior to joining Bio-Imaging, he was Director of Certification and Site Accreditation at the International Society for Clinical Densitometry (ISCD), and was responsible for the administration of ISCD's certification review courses and other continuing education programs. He comes to Bio-Imaging with long-term experience in providing postgraduate physician education and allied health degree programs at all levels.
Mark L. Weinstein, President and Chief Executive Officer of Bio-Imaging Technologies, commented, ``Bio-Imaging ETC is a natural extension of the work we already perform. For the past 10 years, we have provided services to pharmaceutical clients that ensure quality medical images are obtained in their clinical trials. These core services have included education, training and equipment certification and calibration. This new division will be providing these services beyond the clinical trials arena to a broader clinical sector. We are delighted that Len Avecilla has joined us to head up this new endeavor. Len joins us with many years of experience in conducting training programs but also brings vast knowledge of the medical imaging industry.''
Colin Miller, Ph.D., Vice President of Business Development, said, ``There has been a need in the osteoporosis field for instrument certification services. We have been asked over the years if we could provide a service similar to the one we offer in clinical trials, and we are delighted to be able to now offer this to practicing clinicians. The training program has developed out of other Bio-Imaging courses and will be extended to provide a useful entry-level training program for physicians and technologists wishing to understand the fundamentals and economics of bone mineral density testing.''
Len Avecilla stated, ``This is an exciting opportunity to work with a company that is known for its high quality and dedication to service. The formation of this division reflects the extension of quality assurance and educational strategies from the clinical trials domain to the realm of the clinical practitioner. For the first time, these well-validated methods will be available to the bone density and imaging clinical practice setting. The result will be to optimize performance of these crucial diagnostic techniques and raise the standard of care.''
Bio-Imaging Technologies, Inc. is a pharmaceutical contract service organization providing services that support the product development process of the pharmaceutical, biotechnology and medical device industries. The Company has specialized in assisting its clients in the design and management of the medical-imaging component of clinical trials since 1990. Bio-Imaging serves its clients on a global basis through its Corporate headquarters (Newtown, Pennsylvania), U.S. Business Offices (New Jersey, Massachusetts, Washington and California), European office (Leiden, The Netherlands) and European business office in Dusseldorf.
Certain matters discussed in this press release are ``forward-looking statements'' intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
SOURCE: Bio-Imaging Technologies, Inc. |
